• Sukhadeo Baliram Barbuddhe, Deepak Bhiwa Rawool, Pankaj Prakash Gaonkar, Jess Vergis, Kuldeep Dhama, and Satyaveer Singh Malik.
• R&D organisation, ICAR- National Research Centre on Meat , Hyderabad, India.
• Hum Vaccin Immunother. 2020 Dec 1; 16 (12): 3023-3033.

AbstractSevere acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), the etiological agent of the novel coronavirus disease (COVID-19), has posed a great public health threat to the global community as a pandemic. The origin of the virus has been linked to animals, through a yet-to-be-identified intermediate host. The disease is transmitted to humans mainly through inhalation or contact with infected droplets. The variable clinical presentation of COVID-19 includes fever, cough, sore throat, breathlessness, fatigue and malaise; however, cutaneous, ocular, neurological, and gastrointestinal manifestations have also been reported. There is an urgent need to strengthen One Health surveillance, intervention, and management strategies to understand the ecology of coronaviruses and to prevent epidemics in the future. Global attention toward the development of treatments, immunotherapies, vaccines, and control options to combat the COVID-19 pandemic has been on an increasing trend. Here, we review the current epidemiological status, public health concerns, and mitigation strategies for COVID-19.

28 keywords...

hide…